Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.

Biotechnology

Health Care

Pharmaceutical

Matchpoint Therapeutics

Andre Turenne

Paul Renhowe

Mark Jedrychowski, PhD

Jared Cumming

Christopher Hren

Biology and Chemistry Research

Leadership Team

Teams at Matchpoint Therapeutics

Biology and Chemistry Research

Leadership Team